Safe prescription recommendations for non steroidal anti-inflammatory drugs: Consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG)

Angel Lanas, Pere Benito, Joaquín Alonso, Blanca Hernández-Cruz, Gonzalo Barón-Esquivias, Ángeles Perez-Aísa, Xavier Calvet, José Francisco García-Llorente, Milena Gobbo, José R. Gonzalez-Juanatey

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Abstract

This article outlines key recommendations for the appropriate prescription of non steroidal anti-inflammatory drugs to patients with different musculoskeletal problems. These recommendations are based on current scientific evidence, and takes into consideration gastrointestinal and cardiovascular safety issues. The recommendations have been agreed on by experts from three scientific societies (Spanish Society of Rheumatology [SER], Spanish Association of Gastroenterology [AEG] and Spanish Society of Cardiology [SEC]), following a two-round Delphi methodology. Areas that have been taken into account encompass: efficiency, cardiovascular risk, gastrointestinal risk, liver risk, renal risk, inflammatory bowel disease, anemia, post-operative pain, and prevention strategies. We propose a patient management algorithm that summarizes the main aspects of the recommendations. © 2013 Elsevier España, S.L. and AEEH y AEG.
Original languageEnglish
Pages (from-to)68-84
JournalReumatologia Clinica
Volume10
Issue number2
DOIs
Publication statusPublished - 1 Jan 2014

Keywords

  • Adverse event
  • Cardiovascular
  • Gastrointestinal hemorrhage
  • Non steroidal anti-inflammatory drugs
  • Peptic ulcer

Fingerprint

Dive into the research topics of 'Safe prescription recommendations for non steroidal anti-inflammatory drugs: Consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG)'. Together they form a unique fingerprint.

Cite this